Substituted nucleosides, nucleotides and analogs thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9758544
APP PUB NO 20160176911A1
SERIAL NO

14970896

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HCV infection with one or more nucleotide analogs.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALIOS BIOPHARMA INC10 SHOREVIEW STREET SAN FRANCISCO CA 94121

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beigelman, Leonid San Mateo, US 390 10741
Dyatkina, Natalia Mountain View, US 12 666
Smith, David Bernard San Mateo, US 94 2931
Wang, Guangyi Carlsbad, US 90 3414

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 12, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 12, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00